Leon Schurgers

Professor

Leon J. Schurgers is Professor of Biochemistry of Vascular Calcification and, since 2023, Chair of the Department of Biochemistry at Maastricht University. He is also Chair of Stem Cell Research University Maastricht (SCRUM) and section leader of Regenerative & Reconstructive Cardiovascular Medicine within CARIM. 

His research focusses on the molecular mechanisms driving vascular remodelling, cardiovascular ageing and disease, with particular emphasis on vascular smooth muscle cell plasticity, extracellular matrix remodelling, oxidative and mitochondrial stress, extracellular vesicles, mechanobiology and vascular calcification. Building on his longstanding research into vitamin K and matrix Gla protein (MGP), his programme integrates patient-derived vascular tissue with iPSC-based disease modelling to investigate genetic and acquired cardiovascular disorders.

A major current research direction is the modelling of thoracic aortic disease and genetic cardiomyopathies using patient-specific iPSC-derived vascular smooth muscle cells and cardiomyocytes. These cells are incorporated into advanced 3D systems, including engineered 3D vascular and cardiac tissues, enabling cardiovascular disease mechanisms to be studied under physiologically relevant flow and mechanical load. His current work combines 2D and 3D cellular models with molecular profiling and functional phenotyping to investigate how genetic variation, mechanotransduction, cellular stress and ageing converge on cardiovascular dysfunction. 

Ultimately, our group aims to translate insights from vitamin K biology, vascular calcification, genetic cardiovascular disease, human stem-cell models and cardiovascular mechanobiology into biomarkers and novel strategies for preventing or reversing cardiovascular ageing and disease.

Leon-schurgers

Department of Biochemistry
Universiteitssingel 50, 6229 ER Maastricht
PO Box 616, 6200 MD Maastricht
Room number: H1.342
T: +31(0)43 388 16 80

  • 2026
    • Mikolajetz, D., Wu, Z., Romel, C., van der Vorst, E. P. C., Noels, H., Schurgers, L. J., de Leeuw, P., Kroon, A. A., Saritas, T., Moellmann, J., Rau, M., Lehrke, M., Marx, N., Jankowski, V., Jankowski, J., & de la Puente-Secades, S. (2026). Development of a monoclonal antibody targeting the calcification blocking factor CBF. Biomedicine & Pharmacotherapy, 204, Article 119958. https://doi.org/10.1016/j.biopha.2026.119958
    • Husen, T. F., Lotfalla, A., Schreurs, R., Korver, E., Verheule, S., Schurgers, L., Jacobs, M., Lorusso, R., Heuts, S., & Bidar, E. (2026). Advanced organ protection strategies in aortic arch surgery: A narrative review. Perfusion, 41(8), 1347-1363. https://doi.org/10.1177/02676591261466148
    • van Loo, C., Stevens, K. A., Sigaeva, T., Giudici, A., Schurgers, L. J., Delhaas, T., Au, J. S., & Spronck, B. (2026). Biaxial biomechanics of aged human carotid arteries. Journal of the Mechanical Behavior of Biomedical Materials, 182, Article 107529. https://doi.org/10.1016/j.jmbbm.2026.107529
    • Toonen, S. M. R. L., de Raat, F. M., van Loo, C., van Knippenberg, L., van Houte, J., Delhaas, T., Schurgers, L. J., Jeroncic, A., Mischi, M., Arthur Bouwman, R., Montenij, L. J., & Spronck, B. (2026). Vasoactive response of the thoracic aorta to phenylephrine infusion during cardiac surgery. Journal of Applied Physiology, 141(3), 863-872. https://doi.org/10.1152/japplphysiol.00996.2025
    • Barrera-Chimal, J., Lopez-Ramirez, J., Henley, N., Gao, P., Ma, Y., Desjardins-Lecavalier, N., Costantino, S., Royal, V., Agten, S. M., Borras, T., Pichette, V., Yuen, D. A., Schurgers, L. J., & Gerarduzzi, C. (2026). Matrix Gla Protein is a novel regulator of TGFβ–dependent fibroblast activation and kidney fibrosis. Molecular Biomedicine, 7(1), Article 127. https://doi.org/10.1186/s43556-026-00518-0
    • Heuts, S., de Keijzer, A. R., Adriaans, B. P., Notenboom, M. L., Mihl, C., Wildberger, J. E., Vos, R. J., Post, M. C., Rylski, B., Czerny, M., Reesink, K. D., Takkenberg, J. J. M., Veen, K. M., Arabkhani, B., Schalla, S. S., Schurgers, L. J., Lorusso, R., Hjortnaes, J., & Bidar, E. (2026). Rethinking Aortic Risk: The Potential Impact of Novel, Adjusted, and Combined Aortic Measures in the Prediction of Aortic Dissection. The Canadian journal of cardiology, 42(7), 1686-1696. https://doi.org/10.1016/j.cjca.2026.01.023
    • Lotfalla, A., Heuts, S., Schreurs, R., Maessen, J. G., Schurgers, L., Korver, E., Verheule, S., Lorusso, R., Jacobs, M., & Bidar, E. (2026). A Comprehensive Total Body Perfusion Strategy vs Conventional Techniques in Elective Aortic Arch Surgery: A Comparative Analysis. Interdisciplinary CardioVascular and Thoracic Surgery, 41(6), Article ivag145. https://doi.org/10.1093/icvts/ivag145
    • Vossen, L. M., de Leeuw, P. W., Schurgers, L. J., Heuts, S., Adriaans, B. P., de Haan, C., van Varik, B. J., & Kroon, A. A. (2026). Two Years of Menaquinone-7 Supplementation and Coronary Artery Calcification A Randomized Clinical Trial. JAMA Cardiology. Advance online publication. https://doi.org/10.1001/jamacardio.2026.1279
    • Potjewijd, J., Tobal, R., van Doorn, D. P. C., Schurgers, L. J., Heeringa, P., Damoiseaux, J. G. M. C., & van Paassen, P. (2026). Soluble immune checkpoints reflect immune activation and treatment response in high-risk systemic sclerosis patients treated with plasma exchange. Journal of Translational Autoimmunity, 12, Article 100361. https://doi.org/10.1016/j.jtauto.2026.100361
    • Bittner, R., de Vries, F., Machuron, F., Maresz, K., Gaserod, O., & Schurgers, L. (2026). Sex-Specific Effects of Menaquinone-7 (MK-7) Supplementation on Body Composition and Adiposity Markers. Nutrients, 18(11), Article 1699. https://doi.org/10.3390/nu18111699